Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday.
/https://s3.mihaaru.com/photos/2020/08/21/282595_3_5223db10ded8659eeae288e184e47d3f0bbb2266_large.jpg)
This handout picture taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease, developed by the Gamaleya Research Institute of Epidemiology and Microbiology. (Photo by Handout / Russian Direct Investment Fund / AFP) /
2020-11-24 16:33:03
Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday.
The two-dose vaccine will be available on international markets for less than $10 (8.40 euros) per dose, they said, and will be free for Russian citizens.
Copyright © 2025 The Edition
/https://s1.mihaaru.com/photos/2025/03/03/412239_3_0d44335ad3c46bcc013565bc8f2b060cc771eb05_large.jpg)
/https://s1.mihaaru.com/photos/2024/11/18/405822_3_42991b287152e728fb9dc1a34b047616b3c170b2_large.jpg)
/https://s3.mihaaru.com/photos/2025/02/22/411540_3_4a48676775adcce55fa65b35db06d54c556c2d45_large.jpg)
/https://cdn.mihaaru.com/photos/2025/01/20/409609_3_8619638b962d13f7368c9bfe329a353eeeb47616_large.jpg)